Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Kheolamai P"'
Autor:
Sirikul Manochantr, Ladda Meesuk, Nuengruethai Chadee, Jintamai Suwanprateeb, Chairat Tantrawatpan, Pakpoom Kheolamai
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Background Placenta-derived human mesenchymal stem cells (PL-MSCs) have gained a lot of attention in the field of regenerative medicine due to their availability and bone-forming capacity. However, the osteogenic differentiation capacity of
Externí odkaz:
https://doaj.org/article/4322193f23f642aa944b938e40254da7
Autor:
Sujittra Khampang, Chanchao Lorthongpanich, Chuti Laowtammathron, Phatchanat Klaihmon, Sukanya Meesa, Wichuda Suksomboon, Nittaya Jiamvoraphong, Pakpoom Kheolamai, Sudjit Luanpitpong, Charles A. Easley, Eisa Mahyari, Surapol Issaragrisil
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract YAP plays a vital role in controlling growth and differentiation in various cell lineages. Although the expression of YAP in mice testicular and spermatogenic cells suggests its role in mammalian spermatogenesis, the role of YAP in the devel
Externí odkaz:
https://doaj.org/article/923d5e1ad63b41af8fd9c050f9bc7c1b
Autor:
Nittaya Jiamvoraphong, Chanchao Lorthongpanich, Phatchanat Klaihmon, Pakpoom Kheolamai, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 78, Iss , Pp 103466- (2024)
The Rh-negative type O blood group (O Rh-) is considered a universal donor for emergency blood transfusions. Due to the constant shortage of this rare blood group, the production of blood cells from iPSCs derived from the O Rh- donor could potentiall
Externí odkaz:
https://doaj.org/article/7e8b16ae2e9e4a089dba333c9a6108ce
Autor:
Phatchanat Klaihmon, Chanchao Lorthongpanich, Pakpoom Kheolamai, Wannachai Saisaard, Surapol Issaragrisil
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Chronic myelogenous leukemia (CML) is a clonal hematologic malignancy of the myeloid lineage caused by the oncogenic BCR/ABL fusion protein that promotes CML cell proliferation and protects them against drug-induced apoptosis. In this study,
Externí odkaz:
https://doaj.org/article/3e7762c9992a488c9ff56dd679a37ade
Autor:
Gunticha Suwanmanee, Chairat Tantrawatpan, Pakpoom Kheolamai, Luminita Paraoan, Sirikul Manochantr
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-20 (2023)
Abstract Placenta-derived mesenchymal stem cells (PL-MSCs) have therapeutic potential in various clinical contexts due to their regenerative and immunomodulatory properties. However, with increasing age or extensive in vitro culture, their viability
Externí odkaz:
https://doaj.org/article/dced9d926be249a69e446d020c4e878d
Autor:
Chuti Laowtammathron, Chanchao Lorthongpanich, Nittaya Jiamvoraphong, Pimonwan Srisook, Phatchanat Klaihmon, Pakpoom Kheolamai, Sudjit Luanpitpong, Surapol Issaragrisil
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Background In vitro production of hematopoietic stem/progenitor cells (HSPCs) from human-induced pluripotent stem cells (hiPSCs) provides opportunities for fundamental research, disease modeling, and large-scale production of HLA-matched HSP
Externí odkaz:
https://doaj.org/article/12d1c1de258740d8b67336ffc35f0066
Autor:
U-pratya Yaowalak, Tantrawatpan Chairat, Tapanadechopone Pirath, Manochantr Sirikul, Kheolamai Pakpoom, Churdchomjan Worachat, Issaragrisil Surapol
Publikováno v:
BMC Endocrine Disorders, Vol 10, Iss 1, p 5 (2010)
Abstract Background Endothelial progenitor cells (EPCs) play an important role in vascular repair and a decrease in the number of EPCs is observed in type 2 diabetes. However, there is no report on the change of EPCs after glycemic control. This stud
Externí odkaz:
https://doaj.org/article/9cf8a4e0607e40f3989785c6c342c4da
Autor:
Ladda Meesuk, Jintamai Suwanprateeb, Faungchat Thammarakcharoen, Chairat Tantrawatpan, Pakpoom Kheolamai, Iyapa Palang, Duangrat Tantikanlayaporn, Sirikul Manochantr
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-19 (2022)
Abstract Mesenchymal stem cells (MSCs) are a promising candidate for bone repair. However, the maintenance of MSCs injected into the bone injury site remains inefficient. A potential approach is to develop a bone-liked platform that incorporates MSCs
Externí odkaz:
https://doaj.org/article/5d92225117124c7a885feb9ca3f15114
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.